These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1566503)

  • 1. Discordant xenografting: a summary and look to the future.
    Bach FH
    Transplant Proc; 1992 Apr; 24(2):739-42. PubMed ID: 1566503
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunobiology of discordant xenograft rejection and potential therapeutic modalities.
    Robson SC; Candinas D; Winkler H; Kopp C; Hancock WW; Bach FH
    Transplant Proc; 1996 Jun; 28(3):1154-5. PubMed ID: 8658607
    [No Abstract]   [Full Text] [Related]  

  • 3. Xenotransplantation: problems and approaches.
    Millan MT; Ferran C; Winkler H; Blakely ML; van der Werf WJ; Hancock WW; Bach FH
    Transplant Proc; 1994 Dec; 26(6):3593-6. PubMed ID: 7998285
    [No Abstract]   [Full Text] [Related]  

  • 4. Discordant xenografting: challenges and controversies.
    Platt JL; Bach FH
    Curr Opin Immunol; 1991 Oct; 3(5):735-9. PubMed ID: 1755990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endothelial cell: an obstacle to xenografting.
    Bach FH
    Pathol Biol (Paris); 1994 Mar; 42(3):213-6. PubMed ID: 8090568
    [No Abstract]   [Full Text] [Related]  

  • 6. Newborn discordant cardiac xenotransplantation in primates: a model of natural antibody depletion.
    Michler RE; Xu H; O'Hair DP; Shah A; Kwiatkowski PA; Minanov O; Itescu S
    Transplant Proc; 1996 Apr; 28(2):651-2. PubMed ID: 8623325
    [No Abstract]   [Full Text] [Related]  

  • 7. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts.
    Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Smith N; Bach FH
    J Immunol; 1999 Sep; 163(5):2850-7. PubMed ID: 10453031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenotransplantation of discordant, immediately-vascularized organs.
    Bach FH
    Clin Transplant; 1993 Feb; 7(1 part 2):90-2. PubMed ID: 10148368
    [No Abstract]   [Full Text] [Related]  

  • 9. Human xenoreactive natural antibodies--avidity and targets on porcine endothelial cells.
    Vanhove B; Bach FH
    Transplantation; 1993 Nov; 56(5):1251-3. PubMed ID: 8249132
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanisms of xenotransplant rejection].
    Candinas D; Seebach JD
    Zentralbl Chir; 1999; 124(7):591-9. PubMed ID: 10474871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cells in xenotransplantation: do they accommodate?
    Bach FH; Stuhlmeier KM; Vanhove B; Van der Werf WJ; Blakely ML; de Martin R; Hancock WW; Winkler H
    Transplant Proc; 1994 Jun; 26(3):1167-9. PubMed ID: 8029873
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of bursectomy on deposition of natural xenoreactive antibodies and complement within rat cardiac xenografts in the chicken.
    Pruitt SK; Weinstock D; Suyemoto MM; Sanfilippo F; Baldwin WM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):435-7. PubMed ID: 8438367
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
    Lin Y; Sobis H; Vandeputte M; Waer M
    Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012
    [No Abstract]   [Full Text] [Related]  

  • 14. Xenograft rejection--molecular mechanisms and therapeutic implications.
    Magee JC; Platt JL
    Ther Immunol; 1994 Jan; 1(1):45-58. PubMed ID: 7584479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts.
    Soares M; Lu X; Havaux X; Baranski A; Reding R; Latinne D; Daha M; Lambotte L; Bach FH; Bazin H
    Transplantation; 1994 Apr; 57(7):1003-9. PubMed ID: 8165695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell- and macrophage mediated discordant guinea pig-->rat xenograft rejection in the absence of complement, xenoantibody and T cell immunity.
    Xia G; Ji P; Rutgeerts O; Waer M
    Transplantation; 2000 Jul; 70(1):86-93. PubMed ID: 10919580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of IgM anti-endothelial antibodies results in prolonged cardiac xenograft survival.
    Fischel RJ; Bolman RM; Platt JL; Najarian JS; Bach FH; Matas AJ
    Transplant Proc; 1990 Jun; 22(3):1077-8. PubMed ID: 2190373
    [No Abstract]   [Full Text] [Related]  

  • 18. The mechanism of discordant xenograft rejection.
    Miyagawa S; Hirose H; Shirakura R; Nakata S; Naka Y; Kitagawa S; Nakano S; Matsumoto M; Seya T; Kitamura H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):520-1. PubMed ID: 2650190
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro and in vivo studies to prevent hyperacute rejection.
    Miyagawa S; Mikata M; Matsuda H; Ikawa M; Okabe M; Nagasawa S; Matsumoto M; Seya T; Shirakura R
    Transplant Proc; 1996 Apr; 28(2):1031-3. PubMed ID: 8623217
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on transfer of primate membrane-associated complement inhibitors from recipient blood to porcine donor organs.
    Kroshus TJ; Bolman RM; Dalmasso AP
    Transplant Proc; 1996 Apr; 28(2):601-2. PubMed ID: 8623295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.